Physician profile
Brian A Lugo
NPI 1497911804
$60,956.19
in general payments reported to CMS, 2019-2025
13 companies · $22K in 2025
The $22K reported for 2025 was more than what 98% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $214 · 2021: $177 · 2022: $161 · 2023: $9,095 · 2024: $29K · 2025: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $49K · Travel and Lodging: $6,651 · Food and Beverage: $4,150 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $49,350.90 |
| Travel and Lodging | $6,651.11 |
| Food and Beverage | $4,149.83 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $56,924.41 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $2,013.70 | 2023-2025 | Progrip, Signia |
| Zimmer Biomet Holdings, INC. | $949.00 | 2023 | Advantagerib |
| Acell, INC. | $254.71 | 2019-2020 | |
| Kls-Martin L.P. | $145.47 | 2020-2022 | |
| Allergan, INC. | $144.50 | 2019 | |
| La Jolla Pharmaceutical Company | $141.57 | 2022 | |
| Kci USA, INC. | $121.49 | 2023 | Prevena |
| Vertex Pharmaceuticals Incorporated | $82.97 | 2025 | |
| Kerecis Limited | $81.96 | 2021 | |
| Pfizer INC. | $48.49 | 2025 | |
| Edwards Lifesciences Corporation | $27.40 | 2020 | |
| Solta Medical, A Division of Bausch Health US, LLC | $20.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lugo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.